118 related articles for article (PubMed ID: 38787285)
1. Leucine-rich repeat-containing G protein-coupled receptor 5 expression in lymph node metastases of colorectal cancer: Clinicopathological insights and prognostic implications.
Sawaguchi H; Uehara T; Iwaya M; Asaka S; Nakajima T; Kamakura M; Nagaya T; Yoshizawa T; Ota H; Umemura T
Pathol Int; 2024 May; ():. PubMed ID: 38787285
[TBL] [Abstract][Full Text] [Related]
2. The role of tumor budding in colorectal adenocarcinoma: Possible involvement of the intestinal cancer stem cell marker Lgr5.
Sadek SA; A Rehim DM; Fatima S
Indian J Pathol Microbiol; 2020; 63(1):32-37. PubMed ID: 32031119
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of leucine-rich repeat-containing G-protein (Lgr5) and its impact on clinicopathological features of colorectal cancer.
Gzil A; Zarębska I; Jaworski D; Antosik P; Durślewicz J; Maciejewska J; Domanowska E; Skoczylas-Makowska N; Ahmadi N; Grzanka D; Szylberg Ł
J Cancer Res Clin Oncol; 2020 Oct; 146(10):2547-2557. PubMed ID: 32671503
[TBL] [Abstract][Full Text] [Related]
4. [Expression of stem cell markers CD44 and Lgr5 in colorectal cancer and its relationship with lymph node and liver metastasis].
Wang XF; Zhang XL; Xu LP; Shi GG; Zheng HY; Sun BC
Zhonghua Yi Xue Za Zhi; 2018 Sep; 98(36):2899-2904. PubMed ID: 30293346
[No Abstract] [Full Text] [Related]
5. Correlation of clinicopathological features and leucine-rich repeat-containing G-protein-coupled receptor 5 expression in pancreatic ductal adenocarcinoma.
Kuraishi Y; Uehara T; Kobayashi Y; Nakajima T; Watanabe T; Shimizu A; Ota H; Tanaka E
Pathol Res Pract; 2019 Nov; 215(11):152623. PubMed ID: 31543221
[TBL] [Abstract][Full Text] [Related]
6. Leucine-rich repeat-containing G-protein-coupled receptor 5 expression and clinicopathological features of colorectal neuroendocrine neoplasms.
Nakajima T; Uehara T; Kobayashi Y; Kinugawa Y; Yamanoi K; Maruyama Y; Suga T; Ota H
Pathol Int; 2018 Jul; ():. PubMed ID: 30043418
[TBL] [Abstract][Full Text] [Related]
7. Leucine-rich repeat-containing G-protein-coupled receptor 5 is associated with invasion, metastasis, and could be a potential therapeutic target in human gastric cancer.
Xi HQ; Cai AZ; Wu XS; Cui JX; Shen WS; Bian SB; Wang N; Li JY; Lu CR; Song Z; Wei B; Chen L
Br J Cancer; 2014 Apr; 110(8):2011-20. PubMed ID: 24594994
[TBL] [Abstract][Full Text] [Related]
8. Role of doublecortin-like kinase 1 and leucine-rich repeat-containing G-protein-coupled receptor 5 in patients with stage II/III colorectal cancer: Cancer progression and prognosis.
Kang XL; He LR; Chen YL; Wang SB
World J Gastroenterol; 2020 Nov; 26(43):6853-6866. PubMed ID: 33268966
[TBL] [Abstract][Full Text] [Related]
9. LGR5 expression and clinicopathological features of the invasive front in the fat infiltration area of pancreatic cancer.
Kamakura M; Uehara T; Iwaya M; Asaka S; Kobayashi S; Nakajima T; Kinugawa Y; Nagaya T; Yoshizawa T; Shimizu A; Ota H; Umemura T
Diagn Pathol; 2022 Feb; 17(1):21. PubMed ID: 35123536
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic and prognostic significance of LGR5, a cancer stem cell marker in patients with colorectal cancer.
Ihemelandu C; Naeem A; Parasido E; Berry D; Chaldekas K; Harris BT; Rodriguez O; Albanese C
Colorectal Cancer; 2019 Nov; 8(4):CRC11. PubMed ID: 32038737
[TBL] [Abstract][Full Text] [Related]
11. Lgr5 over-expression is positively related to the tumor progression and HER2 expression in stage pTNM IV colorectal cancer.
Gao FJ; Chen JY; Wu HY; Shi J; Chen M; Fan XS; Huang Q
Int J Clin Exp Pathol; 2014; 7(4):1572-9. PubMed ID: 24817953
[TBL] [Abstract][Full Text] [Related]
12. Correlation of clinicopathological features and LGR5 expression in colon adenocarcinoma.
Sato K; Uehara T; Iwaya M; Nakajima T; Miyagawa Y; Ota H; Tanaka E
Ann Diagn Pathol; 2020 Oct; 48():151587. PubMed ID: 32829068
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of leucine-rich repeat-containing G protein-coupled receptor 5 in colorectal cancer.
Uchida H; Yamazaki K; Fukuma M; Yamada T; Hayashida T; Hasegawa H; Kitajima M; Kitagawa Y; Sakamoto M
Cancer Sci; 2010 Jul; 101(7):1731-7. PubMed ID: 20384634
[TBL] [Abstract][Full Text] [Related]
14. Intestinal stem cell marker LGR5 expression during gastric carcinogenesis.
Zheng ZX; Sun Y; Bu ZD; Zhang LH; Li ZY; Wu AW; Wu XJ; Wang XH; Cheng XJ; Xing XF; Du H; Ji JF
World J Gastroenterol; 2013 Dec; 19(46):8714-21. PubMed ID: 24379591
[TBL] [Abstract][Full Text] [Related]
15. Inverse correlation between PD-L1 expression and LGR5 expression in tumor budding of stage II/III colorectal cancer.
Sato K; Uehara T; Nakajima T; Iwaya M; Miyagawa Y; Watanabe T; Ota H
Ann Diagn Pathol; 2021 Jun; 52():151739. PubMed ID: 33862415
[TBL] [Abstract][Full Text] [Related]
16. LGR5 overexpression confers poor relapse-free survival in breast cancer patients.
Hou MF; Chen PM; Chu PY
BMC Cancer; 2018 Feb; 18(1):219. PubMed ID: 29471794
[TBL] [Abstract][Full Text] [Related]
17. Correlation of clinicopathological features and LGR5 expression in colon adenocarcinoma.
Sato K; Uehara T; Iwaya M; Nakajima T; Miyagawa Y; Suga T; Ota H; Tanaka E
Ann Diagn Pathol; 2019 Jun; 40():161-165. PubMed ID: 31100646
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneous expression of Lgr5 as a risk factor for focal invasion and distant metastasis of colorectal carcinoma.
Zheng Z; Yu H; Huang Q; Wu H; Fu Y; Shi J; Wang T; Fan X
Oncotarget; 2018 Jul; 9(53):30025-30033. PubMed ID: 30046385
[TBL] [Abstract][Full Text] [Related]
19. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
Stanisavljević L; Myklebust MP; Leh S; Dahl O
Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of cancer stem cell marker Lgr5 in colorectal cancer patients and association with clinicopathological findings.
Shekarriz R; Montazer F; Alizadeh-Navaei R
Caspian J Intern Med; 2019; 10(4):412-416. PubMed ID: 31814939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
